NeXstar Pharmaceuticals Report issue

For profit Phase 3
Founded: Boulder CO United States (1991)
Status: Acquired by Gilead Sciences (1999)

Organization Overview

First Clinical Trial
1999
NCT00002093
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2000

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Nexstar Pharmaceuticals

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Aspergillosis (Phase 3)

Sarcoma (Phase 3)

Sarcoma, Kaposi (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 5